Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For anyone following retatrutide or taking part in a trial, that means one place for a shot log, body diagram site tracking, side effect notes, food logging, the medication graph, and the long weight trend
Yes, but typically with less intensity than your initial experience
Reports of users with active or prior malignancy avoiding the compound outright on the mechanistic grounds described above
We need to see how patients fare over several years, not just several months, to truly understand the risk-benefit profile before we can determine its ultimate place in treatment. Having medications like eloralintide, which work through a different mechanism, may provide a vital alternative and increase our ability to personalize treatment for the individual
Every patient's journey is unique, and treatment decisions should always be made in consultation with a qualified healthcare professional
no serious ADRs were reported
